AR226522A1 - Procedimiento para preparar derivados de acidos hidroxiaminohidrocarburofosfonico - Google Patents

Procedimiento para preparar derivados de acidos hidroxiaminohidrocarburofosfonico

Info

Publication number
AR226522A1
AR226522A1 AR268576A AR26857677A AR226522A1 AR 226522 A1 AR226522 A1 AR 226522A1 AR 268576 A AR268576 A AR 268576A AR 26857677 A AR26857677 A AR 26857677A AR 226522 A1 AR226522 A1 AR 226522A1
Authority
AR
Argentina
Prior art keywords
hydroxyaminohydrocarbon
preparing
procedure
acid derivatives
phosphonic acid
Prior art date
Application number
AR268576A
Other languages
English (en)
Spanish (es)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of AR226522A1 publication Critical patent/AR226522A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
AR268576A 1976-07-27 1977-07-27 Procedimiento para preparar derivados de acidos hidroxiaminohidrocarburofosfonico AR226522A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3133976 1976-07-27
GB4222276 1976-10-11
GB31339/76A GB1580899A (en) 1976-07-27 1977-06-20 Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof

Publications (1)

Publication Number Publication Date
AR226522A1 true AR226522A1 (es) 1982-07-30

Family

ID=27258468

Family Applications (1)

Application Number Title Priority Date Filing Date
AR268576A AR226522A1 (es) 1976-07-27 1977-07-27 Procedimiento para preparar derivados de acidos hidroxiaminohidrocarburofosfonico

Country Status (21)

Country Link
US (1) US4182758A (fr)
JP (1) JPS5340720A (fr)
AR (1) AR226522A1 (fr)
AT (2) AT367064B (fr)
CA (1) CA1091241A (fr)
CH (5) CH640862A5 (fr)
DE (2) DE2733658A1 (fr)
DK (1) DK149609C (fr)
ES (3) ES461084A1 (fr)
FI (1) FI64377C (fr)
FR (1) FR2474505A1 (fr)
GB (1) GB1580899A (fr)
GR (1) GR61140B (fr)
HU (1) HU182023B (fr)
IE (1) IE45536B1 (fr)
NL (1) NL7708325A (fr)
NO (1) NO157504C (fr)
OA (1) OA05725A (fr)
PH (1) PH14401A (fr)
PT (1) PT66854B (fr)
SE (1) SE441360B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4084953A (en) * 1977-03-09 1978-04-18 Monsanto Company N-hydroxy-N-phosphonomethylglycines and the herbicidal use thereof
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
JPH0340299U (fr) * 1989-08-31 1991-04-18
CN1297352A (zh) 1998-04-14 2001-05-30 哈桑·朱马 有机磷化合物在治疗和预防性治疗感染中的应用
DE19825585A1 (de) * 1998-04-14 1999-10-21 Hassan Jomaa Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
US6753324B2 (en) 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
EE200100027A (et) 1998-07-15 2002-06-17 Jomaa Hassan Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
AU5034899A (en) * 1998-07-15 2000-02-07 Jomaa Hassan Drugs containing phosphoric acid derivatives as active ingredient and their use
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
WO2001060829A1 (fr) * 2000-02-18 2001-08-23 Jomaa Pharmaka Gmbh Composes organophosphores et leur utilisation
DE10035189A1 (de) * 2000-07-20 2002-02-21 Hassan Jomaa Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff
CN101282730A (zh) * 2005-10-06 2008-10-08 依奈特制药公司 有机碱的磷酸抗原盐及其结晶方法
JP5198877B2 (ja) * 2006-01-31 2013-05-15 株式会社エーピーアイ コーポレーション ベンゾアゼピノン類の製造方法
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
EP2404601A1 (fr) 2010-07-06 2012-01-11 BioAgency AG Nouvelles combinaisons de médicaments pour le traitement du paludisme
EP2725029A1 (fr) * 2012-10-29 2014-04-30 Laboratoire Biodim Nouveaux composés antibactériens et leurs applications biologiques
WO2019246119A1 (fr) * 2018-06-18 2019-12-26 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Antibiotiques destinés aux infections staphylococciques vétérinaires
US20220401462A1 (en) 2019-10-19 2022-12-22 Dmg Deutsche Malaria Gmbh Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives with clindamycin and artesunate
EP3960176A1 (fr) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquine et combinaisons de médicaments apparentés pour leur utilisation dans le traitement du covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6905272A (fr) 1968-05-15 1969-11-18
US3764677A (en) * 1971-06-25 1973-10-09 Gates Rubber Co Diethyl betaaminoethylphosphonate as an antimicrobial agent

Also Published As

Publication number Publication date
PT66854B (en) 1978-12-28
DK149609C (da) 1987-02-09
CA1091241A (fr) 1980-12-09
ATA564879A (de) 1981-11-15
CH646979A5 (de) 1984-12-28
CH646980A5 (de) 1984-12-28
US4182758A (en) 1980-01-08
FR2474505A1 (fr) 1981-07-31
FI772280A (fr) 1978-01-28
DK337877A (da) 1978-01-28
CH640862A5 (de) 1984-01-31
JPS5340720A (en) 1978-04-13
DK149609B (da) 1986-08-11
DE2733658C2 (fr) 1987-06-25
NO157504B (no) 1987-12-21
PH14401A (en) 1981-06-25
OA05725A (fr) 1981-05-31
JPS613799B2 (fr) 1986-02-04
GR61140B (en) 1978-09-23
DE2733658A1 (de) 1978-02-09
PT66854A (en) 1977-08-01
GB1580899A (en) 1980-12-10
FR2474505B1 (fr) 1984-01-27
ES479211A1 (es) 1979-12-16
IE45536L (en) 1978-01-27
ES471822A1 (es) 1979-10-16
NO157504C (no) 1988-03-30
ES461084A1 (es) 1978-12-01
CH646978A5 (de) 1984-12-28
ATA550977A (de) 1981-10-15
NL7708325A (nl) 1978-01-31
AT367430B (de) 1982-07-12
IE45536B1 (en) 1982-09-22
FI64377C (fi) 1983-11-10
NO772652L (no) 1978-01-30
DE2760320C2 (fr) 1988-11-03
CH647807A5 (de) 1985-02-15
SE7708592L (sv) 1978-01-28
FI64377B (fi) 1983-07-29
HU182023B (en) 1983-12-28
SE441360B (sv) 1985-09-30
AT367064B (de) 1982-05-25

Similar Documents

Publication Publication Date Title
ES494352A0 (es) Procedimiento para preparar derivados de acidos quinolina- carboxilicos
AR226522A1 (es) Procedimiento para preparar derivados de acidos hidroxiaminohidrocarburofosfonico
AR230452A1 (es) Procedimiento para preparar compuestos de acidos 7-sustituido-3-cefem-4-carboxilicos
MX5449E (es) Procedimiento para preparar acidos hidroxidifosfonicos
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
AR225143A1 (es) Procedimiento para preparar derivados de fenil-metil-hidantoina
MX4899E (es) Procedimiento para preparar derivados de espirohidantoina
MX4652E (es) Procedimiento para preparar aril-3-oxazolidinonas-2
MX4881E (es) Procedimiento para preparar derivados de aminoalcoholes heterociclicos
MX4883E (es) Procedimiento para preparar amidinoureas
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
MX4597E (es) Procedimiento para preparar gamma-pironas
AR227525A1 (es) Procedimiento para obtener derivados de acidos ciclohexancarboxilicos
DK455877A (da) Fremgangsmaade til fremstilling af phenyleddikesyrederivater
MX4594E (es) Procedimiento para preparar combuestos de 3-halometilcefem
AR222453A1 (es) Procedimiento para preparar 3-amino-4-carboxi-tiofenos
MX4911E (es) Procedimiento para preparar derivados de quinoleina
AR229152A1 (es) Procedimiento para obtener derivados de acidos de 1-tioalcanoilprolina
MX4711E (es) Procedimiento para preparar derivados-be-n-(1-alil-2-pirrolidilmetil)-2-3-dimetoxi-5-sulfamoilbenzamida
AR203228A1 (es) Procedimiento para preparar derivados de acidos naftil-carbonolamino-alquil fenoxialquilcarboxilicos
NO821484L (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
AR228020A1 (es) Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona
AR228336A1 (es) Procedimiento para preparar compuestos de 3-clorometilcefem
MX3964E (es) Procedimiento para preparar oxo-benzopiranos
AR223177A1 (es) Procedimiento para preparar derivados de indolo-isoquinolina